Since publication of the original manuscript, the authors have carried out some additional research and can now unambiguously confirm the reassignment of a few late-stage, intermediate compounds that were incorrectly assigned in the original manuscript. Specifically, they have obtained an X-ray structure of the product of Amberlyst^®^ treatment of the mixture of compounds **32** and **S2** and the product obtained is epimeric at C7. To avoid confusion, this new product is called product ***ent*-12A**. An updated and corrected [Scheme 5](#sch1){ref-type="fig"} is provided below.

![Synthesis of *ent*-isoineleganolide A (**29**) and X-ray crystal structure of *ent-epi*-isoineleganolide B (***ent*-12A**).](c8sc90236d-s5){#sch1}

Additional Supplementary Information is provided, containing details of the newly solved X-ray crystal structure.

For a complete discussion, please see the authors' recently published account of their research program toward the enantioselective synthesis of ineleganolide.[@cit1]

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.

Supplementary Material
======================

Supplementary information

###### 

Click here for additional data file.

Crystal structure data

###### 

Click here for additional data file.

[^1]: †Electronic supplementary information (ESI) available: X-ray crystal structure analysis of enone ***ent*-12A**. CCDC [1885720](1885720). For ESI and crystallographic data in CIF or other electronic format see DOI: [10.1039/c8sc90236d](10.1039/c8sc90236d)
